Eular recommendations for the management of early arthritis: Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

¹ Immunorhumatologie,CHU Lapeyronie,Montpellier, France
² University Hospital, Maastricht, Netherlands
³ University of Medicine ,Cluj-Napoca, Romania
⁴ University Hospital Leiden, Netherlands
⁵ Cochin Hospital,Paris, France
⁶ Academic Unitof Musculoskeletal diseases, Leeds, United Kingdom
⁷ Division of Rheumatology, Catholic University of the Sacred Heart,Roma, Italy
⁸ University Hospital Rotterdam, Netherlands
⁹ Karolinska Hospital,Stockholm, Sweden
¹⁰ Internal Medicine III,Medical University, Vienna, Austria
¹¹ Hospital Universitario La Paz,Madrid, Spain
¹² Rheumatology Q,University Hospital ,Herlev, Denmark
¹³ ARC Unit, Manchester University, United Kingdom
¹⁴ Cerrahpasa medical faculty,Istanbul, Turkey

^* To whom correspondence should be addressed. E-mail: b-combe{at}chu-montpellier.fr.

Accepted 4 January 2006

	Abstract

Objectives: To formulate EULAR recommendations for the management of early arthritis

Methods: In accordance with EULAR's "standardised operating procedures", the task force pursued an evidence-based approach and an approach based on expert opinion. A steering group comprised of 14 rheumatologists representing 10 European countries. The group defined the focus of the process, the target population, and formulated an operational definition of "management". Each participant was invited to propose issues of interest regarding the management of early arthritis or early RA. Fifteen issues for further research were selected by use of a modified Delphi technique. A systematic literature search was perfomed. Evidence was categorised according to usual guidelines. A set of draft recommendations was proposed on the basis of the research questions and the results of the literature search.. The strength of the recommendations was based on the category of evidence and expert opinion.

Results: Fifteen research questions, covering the entire spectrum of "management of early arthritis" were formulated for further research. 284 studies were identified and evaluated. Twelve recommendations for the management of early arthritis were selected and presented with short sentences. The selected statements included recognition of arthritis, referral, diagnosis, prognostic, classification and treatment of early arthritis (information, education, nonpharmacological interventions, pharmacological treatments and monitoring of the disease process). On the basis of expert opinion, 11 items were identified as being important for future research.

Conclusion: Twelve key recommendations for the management of early arthritis or early RA were developed, based on evidence in literature and expert consensus.

Keywords: DMARDs, early arthritis, management, recommendations, rheumatoid arthritis

This article has been cited by other articles:

				T Karonitsch, D Aletaha, M Boers, S Bombardieri, B Combe, M Dougados, P Emery, D Felson, J Gomez-Reino, E Keystone, et al. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis Ann Rheum Dis, October 1, 2008; 67(10): 1365 - 1373. [Abstract] [Full Text] [PDF]

				L. H. D. van Tuyl, A. M. C. Plass, W. F. Lems, A. E. Voskuyl, P. J. S. M. Kerstens, B. A. C. Dijkmans, and M. Boers Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis Rheumatology, October 1, 2008; 47(10): 1571 - 1576. [Abstract] [Full Text] [PDF]

				B. Fautrel, R. M. Flipo, and A. Saraux Eligibility of rheumatoid arthritis patients for anti-TNF-{alpha} therapy according to the 2005 recommendations of the French and British Societies for Rheumatology Rheumatology, September 15, 2008; (2008) ken348v1. [Abstract] [Full Text] [PDF]

				H Makinen, P Hannonen, and T Sokka Sex: a major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis? Ann Rheum Dis, July 1, 2008; 67(7): 1052 - 1053. [Full Text] [PDF]

				N. Adib, K. Hyrich, J. Thornton, M. Lunt, J. Davidson, J. Gardner-Medwin, H. Foster, E. Baildam, L. Wedderburn, and W. Thomson Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study Rheumatology, July 1, 2008; 47(7): 991 - 995. [Abstract] [Full Text] [PDF]

				E H S Choy, C M Smith, V Farewell, D Walker, A Hassell, L Chau, D L Scott, and for the CARDERA (Combination Anti-Rheumatic Drugs Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis Ann Rheum Dis, May 1, 2008; 67(5): 656 - 663. [Abstract] [Full Text] [PDF]

				S W Syversen, P I Gaarder, G L Goll, S Odegard, E A Haavardsholm, P Mowinckel, D van der Heijde, R Landewe, and T K Kvien High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study Ann Rheum Dis, February 1, 2008; 67(2): 212 - 217. [Abstract] [Full Text] [PDF]

				S M van der Kooij, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, A J Peeters, M V van Krugten, F C Breedveld, B A C Dijkmans, and C F Allaart Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity score Ann Rheum Dis, February 1, 2008; 67(2): 266 - 269. [Abstract] [Full Text] [PDF]

				K. L Hyrich Patients with suspected rheumatoid arthritis should be referred early to rheumatology BMJ, January 26, 2008; 336(7637): 215 - 216. [Full Text] [PDF]

				M F Bakker, J W G Jacobs, S M M Verstappen, and J W J Bijlsma Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii56 - iii60. [Abstract] [Full Text] [PDF]

				T. P. M. Vliet Vlieland Non-drug care for RA is the era of evidence-based practice approaching? Rheumatology, September 1, 2007; 46(9): 1397 - 1404. [Abstract] [Full Text] [PDF]

				A. Finckh and M. H. Liang Anti-Cyclic Citrullinated Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis: Bayes Clears the Haze Ann Intern Med, June 5, 2007; 146(11): 816 - 817. [Full Text] [PDF]

				D. L. Scott Early rheumatoid arthritis Br. Med. Bull., May 31, 2007; (2007) ldm011v1. [Abstract] [Full Text] [PDF]

eLetters: